Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer.
Adam G SowalskyInes FigueiredoRosina T LisIlsa ColemanBora GurelDenisa BogdanWei YuanJoshua W RussoJohn R BrightNichelle C WhitlockShana Y TrostelAnson T KuRadhika A PatelLawrence D TrueJonathan WeltiJuan M Jimenez-VacasDaniel Nava RodriguesRuth RiisnaesAntje J NeebCynthia T SprengerAmanda SwainScott WilkinsonFatima KarzaiWilliam L DahutSteven P BalkEva CoreyPeter S NelsonMichael C HaffnerStephen R PlymateJohann S de BonoAdam SharpPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
This study demonstrates that further analytical validation and clinical qualification are required before AR-V7 can be considered for clinical use in CSPC as a predictive biomarker.